Clin2
NCT06953180Likely a fitRecruiting

Epigenetics, aging, and disease prevention study in Kazakhstan

Cardiovascular Diseases (CVD)Type 2 DiabetesChronic Respiratory DiseasesObesity (Disorder)Chronic Kidney Diseases

Part of Heart & circulation, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.

This study looks at how your genes and environment affect your risk for non-communicable diseases like heart disease or diabetes. It aims to predict your biological age and help create personalized prevention plans.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
6,720 people
Ages
18 years to 69 years
Study type
Observational

Who can take part

  • You must be between 18 and 69 years old.
  • You must live in one of the 17 regions of Kazakhstan.
  • You must agree to take part and sign a consent form.
  • You must be willing to complete all study procedures.
  • You cannot be under 18 or over 69 years old.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07547098Recruiting
Heart, Kidney, and Metabolism Health Long-Term Study

This research study tracks patients with heart disease, kidney disease, or metabolic conditions (like diabetes) over time to understand how these conditions connect and affect long-term health. By collecting medical records and health information, researchers aim to predict outcomes and improve care.

Fuzhou, Fujian
NCT07570667Not yet recruiting
Health monitoring study with blood tests for disease prevention

This study tracks your health over time through questionnaires and blood tests to catch diseases early. Researchers will follow your health records to see if personalized care recommendations help prevent serious illnesses like heart disease or cancer.

Hong Kong
NCT07038213Enrolling by invitation
Study of kidney protection in type 2 diabetes

This study looks at how genes may affect kidney disease in people with type 2 diabetes. It tests treatments to protect the kidneys. If you are of Kazakh ethnicity and have type 2 diabetes, you may be able to join.

Astana
NCT07727915Enrolling by invitation
Using genetics to predict chronic disease risk

This trial uses genetic information to help predict your risk of developing chronic diseases. It aims to create a platform that can identify health risks earlier so you can take preventive steps.

Medellín, Antioquia
NCT05216042Recruiting
Study of genetics and heart/metabolic health in adults

This study looks at how genetic markers (DNA) relate to heart health and “metabolic” health (how your body manages sugar and fat). You may be asked to provide genetic samples and follow study health checks and protocols to help researchers understand who is at higher risk.

Birmingham, Alabama
NCT07574359Recruiting
Russian Biological Age Study and Aging Patterns

This research study creates a calculator to measure your 'biological age'—how fast your body is aging—based on health markers. Researchers will study aging patterns in Russian adults to better understand healthy aging and develop tools for predicting age-related health changes.

Moscow

Hear when a new Cardiovascular Diseases (CVD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.